STOCK TITAN

VSee Health delays Q3 2026 report for auditor review

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
NT 10-Q

Rhea-AI Filing Summary

VSee Health, Inc. (VSEE) said it could not timely file its Form 10-Q for the quarter ended September 30, 2026, because its auditors needed additional time to complete their final review and sign-off of the financial statements and other disclosures. The company expects to file the report within the five-day extension period provided under Rule 12b-25.

Filing extension 5 days Expected filing period for the Form 10-Q under Rule 12b-25.
Rule 12b-25 regulatory
"five-day extension period provided under Rule 12b-25"
Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why is VSEE's Q3 2026 10-Q late?

VSee Health said its auditors needed additional time to complete their final review and sign-off of the financial statements and other disclosures in the Form 10-Q for the quarter ended September 30, 2026.

When does VSEE expect to file its delayed Q3 2026 10-Q?

VSee Health expects to file it within the five-day extension period provided under Rule 12b-25.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 12b-25

 

 

 

Commission File Number: 001-41015

 

NOTIFICATION OF LATE FILING

 

☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

 

For Period Ended: September 30, 2026

 

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

 

For the Transition Period Ended: _______________________________________

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

 

 

PART I

REGISTRANT INFORMATION

 

Full name of registrant VSee Health, Inc.
Former name if applicable  
Address of principal executive office (street and number) 980 N. Federal Hwy, #304
City, state and zip code Boca Raton, FL 33432

 

 

 

 

PART II

RULE 12b-25 (b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

 

  (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     
☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
     
  (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III

NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR or the transition report or portion thereof, could not be filed within the prescribed time period.

 

VSee Health, Inc. (the “Company”) could not timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (the “Form 10-Q”) because the Company required additional time for its auditors to complete their final review and sign off of the financial statements and other disclosures in the Form 10-Q. The Company expects to file the Form 10-Q within the five-day extension period provided under Rule 12b-25 of the Securities Exchange Act of 1934, as amended. 

 

PART IV

OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

Jerry Leonard,

Chief Financial Officer

  561   672-7068
(Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

 

☒Yes ☐ No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

☐ Yes ☒ No

 

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

1

 

 

VSee Health, Inc.

 

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: November 17, 2026   /s/ Jerry Leonard
  By: Jerry Leonard
  Title: Chief Financial Officer

 

2

 

Keep reading